Skip to content

688428.SH

InnoCare Pharma Ltd.

SSE · CN

CNY 27.54
−6.96%
Ask drillr

Year over year

Reported trailing growth

Revenue
+105.9%
EBITDA
EBIT
+357.3%
EPS
Free cash flow
+85.1%
Operating cash flow
+114.0%

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
+56.0%
EBITDA
+299.7%
EBIT
+245.3%
Net income
+245.8%
EPS
+246.2%
Free cash flow
+103.1%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026